Nalaganje...
Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?
The advent of anti-TNF agents as the first approved targeted therapy in the treatment of inflammatory bowel disease (IBD) patients has made a major impact on our existing therapeutic algorithms. They have not only been approved for induction and maintenance treatment in IBD patients, but have also e...
Shranjeno v:
| izdano v: | Front Med (Lausanne) |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7492550/ https://ncbi.nlm.nih.gov/pubmed/32984386 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2020.00517 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|